NASDAQ · Financial Statements
Adagio Medical Holdings, Inc (ADGM) Financial Statements
$0.13
NASDAQ: ADGM
Market Cap $2.89M
Overview Financials Dividend
Adagio Medical Holdings, Inc most recently reported annual revenue of $0, a net loss of $25.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025
Revenue $0 $0 $0 $0 $0 Operating Profit $-21.0M $-24.0M $-28.0M $-62.0M $-22.0M Net Profit $-20.0M $-24.0M $-38.0M $-54.0M $-25.0M EPS $-0.34 $-1.23 $-0.16 $-3.54 $-1.51 Op Margin -7646.3% -12652.4% -9314.0% -23226.8% —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025
Total Assets $21.0M $9.0M $7.0M $48.0M $43.0M Total Liabilities $94.0M $105.0M $139.0M $29.0M $31.0M Cash $19.0M $6.0M $1.0M $21.0M $17.0M Borrowings $0 $10.0M $38.0M $16.0M $22.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $-19.0M $-22.0M $-1.0M $-29.0M $-19.0M Investing Cash Flow $-3.0M $-1.0M $114.0M $-3.0M $-1.0M Financing Cash Flow $0 $0 $-115.0M $0 $0 Net Cash Flow $-20.0M $5.0M $-6.0M $21.0M $-3.0M Free Cash Flow $-21.0M $-23.0M $-1.0M $-31.0M $-19.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -0.91 FCF Yield -560.93% Quick Ratio 1.15 Interest Coverage -6.38 Return 1Y -60.70% Return 3Y — Return 5Y —
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .